Treatment.com AI completed the acquisition of Rocket Doctor, aligning AI-powered clinical intelligence with a proven virtual care delivery platform.‏Rocket Doctor patient volume grew 112% in Alberta year-over-year, with over 36,000 patients seen in 2024 and physician adoption growing 218%.‏New partnerships launched in California and Canada, including with Central California Alliance for Health, a ~450,000 member managed care plan and Melanoma Canada, a National organization.‏Medical Education Suite deploye ...

Core Insights - A federal court ruling has increased Alignment Healthcare's Arizona HMO 2025 star rating from 3.5 to 4 stars, resulting in 100% of its Medicare Advantage members being enrolled in plans rated 4 stars or higher [1][2] Company Overview - Alignment Healthcare serves approximately 217,500 Medicare beneficiaries across five states: Arizona, California, Nevada, North Carolina, and Texas [3] - The company has received accolades such as a 4.9 out of 5-star Google rating and being named a Newsweek World's Most Trustworthy Company 2024 [3] Quality of Care - The Star Ratings program evaluates Medicare Advantage plans annually on a 5-star scale based on various quality measures, including preventive care, chronic disease management, customer service, and member satisfaction [2] - Plans that achieve 4 stars or higher qualify for bonus payments from CMS, which are reinvested to enhance member benefits and services [2] Strategic Positioning - The court's decision affirms the quality of care provided by Alignment Healthcare and enhances the confidence of Arizona members in their plan's quality [2] - The company aims to deliver more value to its members and provider partners, reinforcing its commitment to high-quality Medicare Advantage services [3] Mission and Values - Alignment Health focuses on empowering seniors to age well and live vibrant lives, emphasizing high-quality, low-cost care for its Medicare Advantage members [4] - The company partners with trusted local providers to deliver coordinated care, supported by a customized care model and a 24/7 concierge care team [4]

So talk to me about your company. Is it all about AI. Is that the difference between your company and some of these other stocks facing a lot of pressure or is there a different narrative at play.Look, we've we've been around for 20 years. I'm one of the founders of the company as is Evan Roberts. And our view has been how do we make care easier for patients and caregivers every single day.And as we've grown, uh, we've adapted and adopted new technology like AI and we've been using it throughout our our bus ...

Company Overview - Phreesia is a leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care[8] - The company operates a SaaS platform to manage patient intake and offers an integrated patient payments solution[8] - Phreesia processed $1.4 billion in patient payments in FY19[8] - The company serves approximately 1,600 healthcare provider organizations[8, 22] Financial Performance and Market Opportunity - Phreesia's revenue in FY19 was $100 million, demonstrating over 25% growth[8, 9] - The company estimates a total addressable market (TAM) of approximately $7 billion[9] - Subscription and related services accounted for 44% of FY19 revenue, while payment processing contributed 37%, and life sciences 19%[34] - In Q2 2020, total revenue reached $30.8 million, a 24.4% increase compared to Q2 2019[42] Growth Strategy - Phreesia aims to land new clients, grow its footprint within existing clients, and cross-sell new applications[27] - The company focuses on margin expansion through scale and strategic partnerships and M&A[27] - Phreesia achieved a 107% dollar-based net retention rate in FY19[27]

Core Viewpoint - Centene experienced a significant drop in stock price, closing down over 40% on July 2, resulting in a loss of over $11 billion in market capitalization, with competitors also facing declines [1][2][5] Group 1: Financial Impact - The drop in Centene's shares was primarily due to the withdrawal of its 2025 full-year guidance, indicating a more challenging financial outlook [2][4] - The company received data indicating lower growth in the ACA exchange market and higher morbidity among enrollees, leading to fewer and sicker patients [3][4] - The expected impact on Centene's 2025 diluted earnings per share (EPS) is a reduction of $2.75, which is 38% of the previously expected EPS of greater than $7.25 [4][5] Group 2: Market Valuation - Despite the significant stock sell-off, Wall Street analysts see a more attractive valuation for Centene, with a 12-month price target of $68.87, implying a potential upside of 108.31% from the current price [5][6] - The average price target post-guidance withdrawal is $51, suggesting a 53% upside, which is higher than the 32% average upside prior to the drop [6][7] Group 3: Regulatory Environment - The recent legislation signed into law includes $1 trillion in cuts to Medicaid, which accounted for approximately 46% of Centene's revenue last quarter, potentially leading to 10.3 million to 11.8 million fewer Medicaid recipients over the next decade [8][9] - The reduction in expected Medicaid users could have a more significant and lasting impact on Centene compared to the ACA exchange enrollment issues, which only made up 20% of the firm's total revenue last quarter [9]

As geopolitical tensions rise, Calian continues to deliver mission-critical healthcare to support Canada’s military readinessOTTAWA, Ontario, July 08, 2025 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today announced a $250 million amendment to its Health Care Provider Recruitment (HCPR) contract with the Department of National Defence (DND). This amendment reinforces Calian’s ...

Core Insights - Nutex Health Inc. has received multiple community-driven accolades for its healthcare delivery in the second quarter of 2025, highlighting its commitment to patient care and community service [1][2]. Company Overview - Nutex Health Inc. is a physician-led integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments across 11 states, focusing on primary care and risk-bearing physician networks [1][4]. - The company was founded in 2011 and is headquartered in Houston, Texas, operating through two divisions: Hospital Division and Population Health Management Division [4][5]. Awards and Recognition - The Colony ER Hospital was awarded "Best Urgent/Emergency Care" in April 2025 by The Colony Chamber of Commerce [3]. - Wylie ER received the title of "Best Emergency Room" in April 2025 from C&S Media [3]. - Dr. Michael Brin from Milwaukee ER & Hospital and Dr. Maley from Tucson ER & Hospital both received "Top Doc Awards" in June 2025 from respective local publications [3]. - Texarkana Emergency Center & Hospital was recognized for "Best Emergency Care/Hospital" in June 2025 by Bowie County Tribune and also received "Best Emergency Care" in the "2025 Best of Texarkana Readers' Choice Awards" [3]. - Dr. Tom Vo, the CEO of Nutex Health, was honored as "Most Admired CEO" in June 2025 by the Houston Business Journal [3]. Commitment to Patient Care - The company emphasizes that its recognition stems from a primary focus on patient care, with awards voted on by the communities it serves, reflecting high patient satisfaction and service quality [2][3].

Employment in the mental health industry has grown at a rapid pace since 2020, thanks in part to federal grants funding training programs to expand and improve the workforce https://t.co/LRBCVy4Qwr ...

Core Insights - The Cigna Group Foundation has announced a new round of grants totaling $9 million over three years, focusing on improving the mental health of military veterans by addressing social determinants of health, particularly housing stability [1][6][8] Grant Program Details - The 2025 grant application is open for eligible organizations in select states, closing on August 7, 2025 [2] - The foundation prioritizes grants in regions with high social determinant of health risks, including Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee, and Texas [3][6] - Goals of the grant program include increasing permanent housing for veterans, improving housing affordability through rental or mortgage assistance, and enhancing wraparound services for veterans transitioning from shelters [3][6] Veteran Mental Health Context - Military veterans face a higher risk of homelessness, with approximately 40,000 veterans without shelter on any given night, and a 7% increase in homelessness among veterans reported from 2022 to 2023 [4][6] Previous Funding Impact - In 2024, the first year of the grant program, $3 million was distributed to 23 organizations to support local veterans, focusing on stability and mental health [5][6] - Examples of funded initiatives include the Veterans Rapid Rehousing Program in Texas and financial assistance for veteran homeowners facing foreclosure in Tennessee [7] Broader Philanthropic Commitment - The Cigna Group Foundation has committed over $27 million in grants over three years to address youth and veteran mental health and reduce barriers to health equity [8]

Core Viewpoint - Centene Corporation is under investigation for potential violations of federal securities laws due to allegations of providing misleading business information, which has led to significant stock price decline following the withdrawal of its earnings guidance [1][4]. Company Overview - Centene is a managed healthcare company that specializes in government-sponsored programs such as Medicaid and Medicare, as well as health insurance plans on individual exchanges and commercial marketplaces [3]. Alleged Wrongdoing - On July 1, 2025, Centene announced its decision to withdraw its 2025 earnings guidance, citing declining market growth in 22 out of the 29 states it operates in. The company indicated that health risks in these states were much higher than previously anticipated in its risk adjustment calculations [4]. - Following this announcement, Centene's stock price dropped by $22.87 per share, representing a 40.37% decline, closing at $33.78 per share on July 2, 2025 [4].